Longeveron
Organisation
People
Chief Science Officer11 Aug 2026assets-us-01.kc-usercontent.com
Team co-lead11 Aug 2026assets-us-01.kc-usercontent.com
Trials
Lomecel-B Effects on Alzheimer's Disease
Phase 2Completed50 people10 Feb 2022clinicaltrials.gov
Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty
Phase 2Completed150 people30 May 2017clinicaltrials.gov
Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty
Phase 1/2Completed62 people6 Dec 2016clinicaltrials.gov
Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease
Phase 1Completed33 people9 Nov 2015clinicaltrials.gov
Safety and Efficacy Trial Using Allogeneic Human Mesenchymal Stem Cells: The SIRONA Trial
Phase 2Withdrawn0 people27 Oct 2015clinicaltrials.gov
Phase 1/2Completed65 people17 Feb 2014clinicaltrials.gov
Grants and prizes
Milestone 2 awardUS$1mPrize11 Aug 2026xprize.org
Milestone 1 awardUS$250kPrize12 May 2025xprize.org
Competes in
Finalist11 Aug 2026xprize.org